Tumor Angiogenesis: A New Significant and Independent Prognostic Indicator in Early-Stage Breast … -
N Weidner, J Folkman, F Pozza, P Bevilacqua, EN … - jnci, 1992 - jnci.oxfordjournals.org
... Journal of the National Cancer Institute, Vol. ... Tumor Angiogenesis: A New Significant
and Independent Prognostic Indicator in Early-Stage Breast Carcinoma. ...
Reduction in New Metastases in Breast Cancer with Adjuvant Clodronate Treatment -
IJ Diel, EF Solomayer, SD Costa, C Gollan, R … - New England Journal of Medicine, 1998 - content.nejm.org
Original Article from The New England Journal of Medicine -- Reduction in New
Metastases in Breast Cancer with Adjuvant Clodronate Treatment. ...
Adjuvant tamoxifen in early breast cancer: occurrence of new primary cancers. -
T Fornander, LE Rutqvist, B Cedermark, U Glas, A … - Lancet, 1989 - ncbi.nlm.nih.gov
Lancet. 1989 Jan 21;1(8630):117-20. Adjuvant tamoxifen in early breast cancer:
occurrence of new primary cancers. Fornander T, Rutqvist ...
… plus a Monoclonal Antibody against HER2 for Metastatic Breast Cancer That Overexpresses HER2 -
DJ Slamon, B Leyland-Jones, S Shak, H Fuchs, V … - New England Journal of Medicine, 2001 - content.nejm.org
... Article from The New England Journal of Medicine -- Use of Chemotherapy plus a
Monoclonal Antibody against HER2 for Metastatic Breast Cancer That Overexpresses ...
Blood Levels of Organochlorine Residues and Risk of Breast Cancer -
MS Wolff, PG Toniolo, EW Lee, M Rivera, N Dubin - jnci, 1993 - jnci.oxfordjournals.org
... Conclusion: In this population of New York City women, breast cancer was
strongly associated with DDE in serum but not with PCBs. ...
Letrozole, a new oral aromatase inhibitor for advanced breast cancer: double-blind randomized trial … -
P Dombernowsky, I Smith, G Falkson, R Leonard, L … - Journal of Clinical Oncology, 1998 - jco.ascopubs.org
... ARTICLES. Letrozole, a new oral aromatase inhibitor for advanced breast cancer:
double-blind randomized trial showing a dose effect and improved efficacy and ...
Gene expression profiling predicts clinical outcome of breast cancer -
LJ van't Veer, H Dai, MJ van de Vijver, YD He, AAM … - Nature, 2002 - Mass Med Soc
... young women with breast cancer. The researchers also identified multiple genes
associated with poor prognosis, which may become targets of new therapies. ...
Germline mutations of the PTEN gene in Cowden disease, an inherited breast and thyroid cancer … -
D Liaw, DJ Marsh, J Li, PLM Dahia, SI Wang, Z … - Nature Genetics, 1997 - nature.com
... KM & Dennis, M. Cowden's disease: a possible new symptom complex ... protein tyrosine
phosphatase gene mutated in human brain, breast, and prostate cancer. ...
… , a Putative Protein Tyrosine Phosphatase Gene Mutated in Human Brain, Breast, and Prostate Cancer -
J Li, C Yen, D Liaw, K Podsypanina, S Bose, SI … - Science, 1997 - sciencemag.org
... BAC) library with this marker (9). Using new STSs from ... and two of four prostate cancer
cell lines ... same deletion pattern as the original breast xenografts; the ...
Efficacy of breast cancer screening by age. New results from the Swedish Two-County Trial. -
L Tabar, G Fagerberg, HH Chen, SW Duffy, CR Smart, … - Cancer, 1995 - ncbi.nlm.nih.gov
Cancer. 1995 May 15;75(10):2507-17. Efficacy of breast cancer screening by
age. New results from the Swedish Two-County Trial. Tabar ...
Source: Google Scholar |